baber/WOPTO huggingface dataset:
Patent NZ-505373-A (NZ)
Title: Biologically activated monomeric HIV-1 Tat or derivatives thereof for prophylactic and therapeutic vaccinations
Inventor: ENSOLI BARBARA
IPC: A61K38/00
Filed: 1998-11-30
Abstract: A biologically active substantially monomeric and non-oxidized isolated Tat protein is capable of entering activated endothelial cells or dendritic cells at concentrations up to 10nM and performing at least one action selected from activating proliferation, migration and invasion of Kaposi's sarcoma (KS) cells or cytokine-activated endothelial cells, inducing in mice development of KS-lesions in the presence of angiogenic factors or inflammatory cytokines or activating virus replication when added to infected cells, as measured by rescue of a Tat-defective proviruses in HLM-1 cells after addition of exogenous protein and/or transactivation of HIV-1 gene expression in cells transfected with a HIV-1 promoter-reporter plasmid. Also described are pharmaceutical compositions comprising the biologically activated Tat protein. The protein can be used for the prevention or treatment of AIDS, AIDS-associated tumors and HIV infections.
Patent NZ-509046-A (NZ)
Title: Intermediates in the formation of antivirally active heterocyclic azahexane derivatives
Inventor: FASSLER ALEXANDER
IPC: C07C251/76
Filed: 2000-12-20
Abstract: Compounds of formulae (III*), (XII), (XII*), (III), (VII), wherein: R3 is phenyl optionally substituted by one ore more lower alkoxy radicals or cycloalkyl; R4 is phenyl or cyclohexyl substituted in the 4 position by unsaturated heterocyclyl which is optionally substituted by lower alkyl or phenyl-lower alkyl; R5 is isopropyl, sec-butyl, tert-butyl or methylthiomethyl; R6 is lower alkoxycarbonyl; and R7 is an amino protecting group. The compounds are useful in preparing a compound of formula (I)
Patent NZ-509422-A (NZ)
Title: Determination of the critical current for a superconducting conductor by using the part of the resulting magnetic field that is out of phase with the external field
Inventor: BENTZON MICHAEL DELEURAN
IPC: G01R33/12
Filed: 1999-07-15
Abstract: A method for the determination of the critical current for a conductor including superconducting material. The conductor is brought into a superconducting state, and a varying external magnetic field is generated through which said conductor is conveyed. A first measurement means is used to carry out a first contact-free measurement of the resulting magnetic field that occurs as a consequence of the influence of said external magnetic field on the conductor. The part of the resulting magnetic field out of phase with the external magnetic field is determined, and the critical current of the conductor is determined on the basis thereof.
Patent NZ-510485-A (NZ)
Title: A golf ball
Inventor: FOX CHARLES NELSON
IPC: A63B69/00
Filed: 2001-03-13
Abstract: The golfing aid (1) has a body comprising two partially spherical ends (2) with the same radii as each other and having contact points on each end. The contact points of the golfing aid are positioned between 4 and 20 millimeter. The drawing shows how the golfing aid is used to correct a putting stroke. If the aid is hit incorrectly (by not having putter head (5) perpendicular to the indicator line (4)), the aid will veer off to one side. Similar principles will apply for chipping and driving.
Patent NZ-514621-A (NZ)
Title: Waste storage device with bags formed from tube by gripping and rotating means
Inventor: RICHARDS DAVID CHARLES
IPC: B65F1/16
Filed: 2000-04-06
Abstract: A waste storage device (21) includes an inlet aperture (12) and a length of flexible tubing (2) passing through the inlet aperture (12) from a cassette. The flexible tubing (2) is pinched by a par of rollers (111) which can have continuous surfaces or multiple paddles. The waste product is placed into the aperture (12) and the rollers (111) rotate drawing the waste product down into the device and pinching the storage bag above it. The operation can be manually or motor driven.
Patent NZ-518993-A (NZ)
Title: Recovery of metal values from aqueous solutions and slurries
Inventor: JAY BILL
IPC: C22B7/00
Filed: 2000-11-09
Abstract: A process for the recovery or removal of metal species from a solution, a leach solution or slurry comprising the steps of: a) contacting the solution, a leach solution or slurry with a polymeric material, consisting of a solid superhydrophilic polyurethane polymer containing a chelating and/or solvating agent, a water-insoluble polymeric chelating agent dispersed in a water-insoluble carrier solution, and a water-soluble polymeric chelating or coordinating agent to load the polymeric material with metal species; b) separating the loaded polymeric material from the solution or slurry; and c) recovering or removing the metal from the polymeric material, where optionally the leach solution or slurry comprising a metal complex is being contacted with the polymeric material for a period sufficient for the metal to be bound to the polymeric material and at least a portion of the ligands of the metal complex to be displaced there from and returned to the leach solution or slurry to be available or coordinated with further metal values.
Patent NZ-521593-A (NZ)
Title: Hybridisation beacon and method of rapid sequence detection and discrimination
Inventor: FRENCH DAVID JOHN
IPC: C12Q1/68
Filed: 2001-03-28
Abstract: A hybridization beacon which is an oligonucleotide where a) the oligonucleotide has no secondary structure arising from one region of the oligonucleotide hybridizing with another region of the oligonucleotide, b) the oligonucleotide is formed of nucleotide residues of which at least one is labeled with a fluorescent reporter wherein the beacon does not include an associated quencher, c) each reporter-labeled nucleotide residue is positioned internally within the oligonucleotide sequence, d) the oligonucleotide is fully complementary to a known target polynucleotide, and e) the oligonucleotide probe is modified at its 3' end so as to prevent chain extension during PCR amplification. The application also discloses methods of making the hybridization beacon and methods of investigating a polynucleotide target.
Patent NZ-521601-A (NZ)
Title: Public and private mobile communication system having only one GPS receiver and sending GPS signals to all transceivers via LAN
Inventor: KIM KI-WOOK
IPC: H04J3/06
Filed: 2002-09-25
Abstract: An apparatus, comprising: a plurality of Internet protocol base transceiver subsystems; and a private base station controller (38) connected to each of the plurality of Internet protocol base transceiver subsystems, the private base station controller comprising a system clock supply section (50) having a single global positioning satellite (GPS) receiver receiving reference clock information and time of date (TOD) information from a satellite, each of the plurality of Internet protocol base transceiver subsystems comprises: a plurality of Internet protocol private base transceiver subsystems (44-1 to 44- 5); collective base transceiver subsystem (46-1 to 46-5); and a LAN cable (64) connecting each plurality of Internet protocol private base transceiver subsystems to each collective base transceiver subsystem, each collective base transceiver subsystem capable of relaying the reference clock information and the TOD information from the private base station controller to each of the plurality of Internet protocol private base transceiver subsystems.
Patent NZ-524463-A (NZ)
Title: Stable solid dosage forms of amino acids and processes for producing same
Inventor: SPIREAS SPIRIDON
IPC: A61K9/16
Filed: 2001-09-26
Abstract: A stable pharmaceutical formulation in dry dosage form comprising: gabapentin crystals, a mineral acid present in an amount to provide at least 20 ppm of the anion of the mineral acid, based on the weight of gabapentin, the mineral acid being dispersed throughout each gabapentin crystal, and at least one stabiliser, wherein the formulation contains less than 1% by weight of the lactam degradation product of gabapentin after being stored for 3 months at 40°C and 75% relative humidity.
Patent NZ-534485-A (NZ)
Title: Rhamnose binding protein
Inventor: LIPSCOMBE RICHARD J
IPC: A61K38/00
Filed: 2003-02-07
Abstract: An isolated RBP (rhamnose binding protein) which is insoluble in aqueous solution and possesses at least one of the following characteristics: a) a molecular weight of approximately 65-70 kDa and more preferably 66-69 kDa; b) a pI of greater than 10 or less than 3; c) a dissociation constant of approximately 1.5 x 10-6 when bound to the rhamnose moiety of solamargine; d) adapted to bind to a rhamnose affinity column prepared and under the conditions set out according to example 1; e) adapted to be eluted from the column in example 1 with the a 100mM rhamnose solution; f) soluble in highly denaturing buffers containing greater than approximately 2% surfactant; and g) is over expressed in cancer cells relative to non-cancer cells. Also described are methods of diagnosing cancer by detecting RBP levels and methods of treating and diagnosing cancer using RBP agonists.
Patent NZ-538560-A (NZ)
Title: A development system for a dialog system
Inventor: STARKIE BRADFORD CRAIG
IPC: G06F17/28
Filed: 2003-09-05
Abstract: A development system includes a scenario generator for generating a plurality of sample interactions representative of interactions between a dialog system and a user of the dialog system on the basis of definition data for the dialog system. The definition data includes state machine code, prompt data, and recognition data. A simulator generates prompts of sample interactions on the basis of the prompt data, and the scenario generator generates responses to the prompts on the basis of the recognition data. A scenario editor allows a user to modify the sample interactions. A grammar learner then updates the prompt data and the recognition data on the basis of the modified sample interactions. An application builder generates the definition data from specification data provided by a developer, an application template, and/or an existing dialog application
Patent NZ-543213-A (NZ)
Title: Bathroom cleaning composition for removing mold, mildew as well as soap scum
Inventor: MERCADO HEDELIZA MALONZO
IPC: C11D3/395
Filed: 2004-05-18
Abstract: Disclosed is a bathroom cleaning composition which comprises by weight: (a) 0.1% to 10% of a chlorine bleach compound; (b) 0.5 to 5% of an amino oxide surfactant; (c) 0.1 to 3% of an alkali metal silicate; (d) 0.25 to 5% of a builder salt; and (e) the balance being water. The disclosed cleaning composition provides superior soap scum removal in the laboratory testing and still is effective in removing mold and mildew.
Patent NZ-548739-A (NZ)
Title: HCV NS-3 Serine protease inhibitors
Inventor: ROSENQUIST ASA
IPC: C07D/
Filed: 2005-01-28
Abstract: Disclosed are HCV NS-3 serine protease inhibitors of formula I wherein A is C(=OO)R1 or C(=O)NHSO2R2; M is CR7R7'; U is =O or absent, G is -O-, -NRy-, -NRjNRj-; and wherein the rest of the substituents are disclosed within the specification. Also disclosed is the use of a compound of formula I in the manufacture of a medicament for the prophylaxis or treatment of flavivirus infections, including HCV.
Patent NZ-549236-A (NZ)
Title: Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
Inventor: HERDEWIJN PIET
IPC: A61K31/706
Filed: 2005-03-04
Abstract: Disclosed are compounds of formula (II) and (XIX) including pharmaceutically acceptable salts, solvates and stereoisomers thereof, wherein the substituents are defined in the specification, including a heterocyclic nucleobase attached to a first carbon atom of an optionally substituted five-member saturated or monounsaturated heterocyclic group selected from tetrahydrofuranyl, tetrahydrothienyl, dihydrofuranyl and dihydrothienyl and further including a phosphonoalkoxy or phosphonothioalkyl group attached to a second carbon atom of said five-member saturated or mono-unsaturated heterocyclic group, said first carbon atom being adjacent to the heteroatom of said five-member saturated or mono-unsaturated heterocyclic group, and said second carbon atom being adjacent neither to the heteroatom nor to the first carbon atom of said five-member saturated or monounsaturated heterocyclic group and their use for treating viral infections such as Human Immunodeficiency Virus (HIV).
Patent NZ-555226-A (NZ)
Title: Thickener composition for dysphagia patients
Inventor: SLIWINSKI EDWARD LUCIAN
IPC: A23L29/262
Filed: 2004-11-18
Abstract: Use of a composition comprising starch, at least one selected from the group consisting of xanthan gum and methylcellulose, and galactomannan for the preparation of a nutritional product suitable for the treatment of dysphagia patients. Also disclosed are thickened products manufactured from the composition.
Patent NZ-555366-A (NZ)
Title: Packaging with a vent region
Inventor: JONES BETH
IPC: B65D65/40
Filed: 2005-11-15
Abstract: Packaging comprises polymer film with portions of the film sealed together to form an enclosure for the food stuff, said sealed portions being sealed by a film-to-film seal except in a vent region (5) where a lacquer layer (6) is bonded to each portion of film before said portions are sealed together with the lacquer layers cohering, the seal strength of the lacquer-to-lacquer interface (6) being similar to that of the film-to-film interface under predetermined storage conditions, and the seal strength of said lacquer-to-lacquer interface (6) being reduced compared with that of the film-to-film interface at temperatures above those expected under said predetermined storage conditions so that the enclosure is vented to atmosphere by a cohesive peel action in the vent region (5) between said lacquer layers (6).
Patent NZ-564263-A (NZ)
Title: Efficient formation of ad hoc networks
Inventor: ABHISHEK ABHISHEK
IPC: H04B7/00
Filed: 2006-06-22
Abstract: A computerized system for efficient formation of an ad hoc network comprises an ad hoc network convergence module configured to, at least: receive an ad hoc network identifier; generate at least one ad hoc network parameter from the ad hoc network identifier; and parameterize an ad hoc network formation protocol with the at least one ad hoc network parameter; and a networking service configured to, at least, perform the ad hoc network formation protocol parameterized with the at least one ad hoc network parameter.
Patent NZ-569168-A (NZ)
Title: Streptococcus pneumoniae polysaccharide conjugate vaccine comprising 19F-DT conjugate
Inventor: BIEMANS RALPH LEON
IPC: A61K39/09
Filed: 2006-12-20
Abstract: Disclosed are immunogenic compositions of Streptococcus pneumoniae that comprise 10 or more capsular saccharides from different carrier proteins. The composition comprises the serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F and 23F conjugates but does not comprise capsular saccharide from serotype 19A. The serotype 19F capsular saccharide is conjugated to the diphtheria toxoid (DT). The composition is used for the treatment and prevention of disease caused by S. pneumoniae infection by serotype 19A strains.
Patent NZ-571454-A (NZ)
Title: A process for supercritical extraction and separation of lipid materials
Inventor: CATCHPOLE OWEN JOHN
IPC: A23L35/00
Filed: 2006-04-20
Abstract: The disclosure relates to processes for separating a feed material into soluble and insoluble components, by contacting a feed material and a solvent and subsequently separating the solvent containing the soluble components from the insoluble components, wherein the feed material comprises one or more of: at least 1% by mass phosphatidyl serine, at least 1% by mass sphingomyelin, at least 0.3 % by mass acylalkylphospholipids and/or plasmalogens, at least 0.5 % by mass aminoethylphosphonate and/or other phosphonolipids, at least 1% by mass cardiolipin, and at least 0.3% by mass gangliosides; and wherein the solvent comprises: supercritical or near-critical CO2, and a co-solvent comprising one or more C1-C3 monohydric alcohols, and water, wherein the co-solvent makes up at least 10% by mass of the CO2, and the water content of the co-solvent is 0 to 40 % by mass. The disclosure also relates to processes for separating a feed material into soluble and insoluble components, comprising contacting a feed material and a first solvent and subsequently separating the first solvent containing the first soluble components from the first insoluble components, wherein the feed material comprises one or more of: at least 1 % by mass phosphatidyl serine, at least 1% by mass sphingomyelin, at least 0.3 % by mass acylalkylphospholipids and/or plasmalogens, at least 0.5 % by mass aminoethylphosphonate and/or other phosphonolipids, at least 1% by mass cardiolipin, or at least 0.3% by mass gangliosides; and wherein the first solvent comprises supercritical or near-critical CO2. The process then provides contacting the first insoluble components with a second solvent and subsequently separating the second solvent containing the second soluble components from the second insoluble components, wherein the second solvent comprises supercritical or near- critical CO2, and a co-solvent comprising one or more C1-C3 monohydric alcohols, and water, wherein the co-solvent makes up at least 10% by mass of the CO2, and the water content of the co-solvent is 0 to 40% by mass. (62) Divided Out of 546681
Patent NZ-572399-A (NZ)
Title: Mixing sealant ingredients in a non-asphalt thermoplastic container which includes an expanded polymer
Inventor: MAXWELL TED E
IPC: B31B50/02
Filed: 2007-03-30
Abstract: Disclosed is a method for providing a thermoplastic product for use. The method includes: providing a non-asphalt thermoplastic container; providing a volume of the at least one ingredient into the non-asphalt thermoplastic container; and mixing at least a portion of the non-asphalt thermoplastic container and the volume of the at least one ingredient to produce a volume of the thermoplastic product. The container is configured to receive the volume of at least one ingredient for inclusion into a thermoplastic product, and includes an expanded polymer material.
Patent NZ-573297-A (NZ)
Title: Animal treatment formulation and methods of use
Inventor: PETROVSKI KIRO RISTO
IPC: A61K33/24
Filed: 2009-11-25
Abstract: Provided is a formulation for administration to the teat canal of the mammary gland of a non-human animal, the formulation including: a physical barrier material comprising sufficient antibiotic such that the formulation is disintegrates over a period of time after administration to the teat canal. The barrier can be barium or bismuth based material and can contain aluminium stearate as gelling material and the antibiotic can be penicilline or cephalosporine.
Patent NZ-575279-A (NZ)
Title: Metal cutting tools with hard coating applied by a physical vapour deposition process
Inventor: KALSS WOLFGANG
IPC: C08J7/046
Filed: 2007-08-30
Abstract: Disclosed is a workpiece having a body and a wear resistant hard coating system on at least a part of the surface of said body, said system comprising at least one layer of the following composition:(Al1-a-b-c Cra Bb Zc)X where X is at least one of: N, C, CN, NO, CO, CNO; Z is at least one of: W, Mo, Ta, Cb (Nb);wherein there is valid 0.2 < a < 0.5;0.01 < b < 0.2;0.001 < c < 0.04,wherein said at least one layer exhibits a glassy growth structure in the SEM cross-section; and wherein said body being of one of high-speed steel, hardened steel, cemented carbide, cubic boron nitride, cermet and a ceramic material; and wherein the workpiece being a cutting tool of an end mill, a drill, a cutting insert and a gear cutting tool. A process for manufacturing said workpiece is also disclosed, which comprises: (a) providing said workpiece body in a plasma coating vacuum chamber, (b) applying said system to said body by a cathodic arc evaporation during a processing time, (c) establishing a temperature of at least 550 Deg. C to the surface of the coated body during at least a predominant part of said processing time.
Patent NZ-577779-A (NZ)
Title: Method and plant for continously monitoring a water processing ballasted flocculation unit which incoporates a hydrocyclone
Inventor: SAUVIGNET PHILIPPE
IPC: C02F1/00
Filed: 2007-12-26
Abstract: Disclosed is a water treatment plant, and particularly one which relates to a process for treating water filled with dissolved or suspended colloidal impurities. The process comprising; a) placing together in a flocculation zone, said water, at least one ballast constituted by at least one insoluble granular material that is heavier than water and at least one flocculating reagent so as to enable the floc to form; b) introducing the mixture of water and floc thus formed into a settling zone; c) separating the water treated in the top portion of said settling zone from a sludge and ballast mixture resulting from the settling of said floc; d) extracting the mixture of sludge and ballast in the bottom portion of said settling zone and routing said mixture to an agitated intermediate mixing zone; e) extracting the mixture of sludge and ballast present in said intermediate mixing zone and subjecting said mixture to a step of sludge/ballast separation by hydrocyclone separation; f) recycling the underflow of the hydrocyclone separation step in said flocculation zone; and g) extracting a part of the sludge coming from the overflow of the hydrocyclone separation step and recirculating the other part of said sludge in said agitated intermediate mixing zone. Wherein the process further includes the steps of continuously measuring at least one parameter representing the concentration of impurities in the water before or when the water enters said flocculation zone; a step of using the results of said measurement thus performed so as to continuously deduce the amount of ballast that needs to be implemented in order to obtain treated water of a predetermined quality; a step of continuously measuring the ballast concentration in the mixture extracted from said settling zone or in the mixture present in said flocculation zone; a step of deducing from the continuous measurement of the concentration of mixture extracted from said settling zone, the concentration of ballast actually present in said plant; and a step of refilling the flocculation zone with ballast when said concentration of ballast actually present in said plant is lower than a predetermined threshold.
Patent NZ-585943-A (NZ)
Title: A post to support a monitor having a rack in the body of the post and an adjustable collar surounding the post
Inventor: CRAMSIE MATTHEW THOMAS
IPC: A47B21/04
Filed: 2010-06-04
Abstract: A post to support an item is disclosed. The post includes an elongated body having a longitudinally extending cavity, and a longitudinally extending slot providing access to the cavity. At least one rack gear extends longitudinally of the body and is located within the cavity. A collar surrounds the body and is operatively associated with the rack gear to selectively engage the rack gear to retain the collar at a desired position along the body. The collar includes a pawl urged into contact with the gear but movable by an operator from engagement with the gear to provide for movement of the collar along the post.